GO
Loading...

Rite Aid Corp

More

  • Early Glance: Drugstore companies Wednesday, 21 Jan 2015 | 10:45 AM ET

    NEW YORK— Shares of some top drugstore companies are mixed at 10 a.m.:. CVSCaremark rose$. 64 or. 7 percent, to $99.01. Rite Aid fell$. 02 or. 3 percent, to $7.30.

  • Final Glance: Drugstore companies Tuesday, 20 Jan 2015 | 6:36 PM ET

    CVSCaremark fell$. 02 or percent, to $98.37. Rite Aid fell$. 08 or 1.1 percent, to $7.32. WalgBoots rose$. 02 or percent, to $76.05.

  • Midday Glance: Drugstore companies Tuesday, 20 Jan 2015 | 1:33 PM ET

    NEW YORK— Shares of some top drugstore companies are down at 1 p.m.:. CVSCaremark fell$. 45 or. 5 percent, to $97.95. Rite Aid fell$. 20 or 2.7 percent, to $7.20.

  • Most active New York Stock Exchange-traded stocks Tuesday, 20 Jan 2015 | 1:33 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. rose 1.8 percent to $15.55 with 25,747,400 shares traded. Bank of America Corp. fell. 8 percent to $15.26 with 105,959,900 shares traded.

  • Early Glance: Drugstore companies Tuesday, 20 Jan 2015 | 10:33 AM ET

    NEW YORK— Shares of some top drugstore companies are down at 10 a.m.:. CVSCaremark fell$. 51 or. 5 percent, to $97.88. Rite Aid fell$. 06 or. 8 percent, to $7.34.

  • Walgreens December same-store sales beat estimates Tuesday, 6 Jan 2015 | 11:35 AM ET

    Jan 6- Walgreen Co, the largest U.S. pharmacy chain, reported a better-than-expected jump in December comparable store sales, helped by the month containing one more Wednesday and one fewer Sunday than a year ago and higher sales of flu medicine. Walgreen, which gets more than 60 percent of its revenue from prescription drug sales, also sells non-prescription...

  • Dec 23- U.S. drugstore chain operator Walgreen Co reported a better-than-expected quarterly profit, helped by a record number of prescriptions filled, sending its shares up 3.6 percent. The combined cost savings for Walgreen and Alliance Boots in the quarter were about $140 million. Net income attributable to Walgreen rose 16 percent to $809 million, or 85...

  • NEW YORK, Dec 18- The S&P 500 closed out its biggest two-day advance since November 2011 on Thursday, extending a Federal Reserve-fueled rally from the previous session, while tech shares jumped after Oracle results. Oracle Corp jumped 10.2 percent to $45.35, a day after quarterly results topped Wall Street expectations. Shares of Apple climbed 3 percent to...

  • NEW YORK, Dec 18- U.S. stocks advanced more than 1 percent on Thursday, extending a rally from the previous session as tech shares gained with stronger-than-expected results from Oracle. The technology sector, up 2.4 percent, helped fuel the advance, buoyed by a gain of over 8 percent in Oracle Corp, a day after its quarterly results topped Wall Street expectations.

  • NEW YORK, Dec 18- U.S. stocks climbed more than 1 percent on Thursday, extending a rally from the previous session as tech shares gained with upbeat results from Oracle. The technology sector, up 2.2 percent, helped fuel the advance, buoyed by a gain of over 8 percent in Oracle Corp, a day after its quarterly results topped Wall Street expectations.

  • Dec 18- Rite Aid Corp, the third largest U.S. drugstore chain, raised its full-year earnings forecast after cutting it twice this year as higher sales of prescription drugs pushed up its profit and revenue in the third quarter. Rite Aid's shares jumped 13.3 percent to $6.87 in heavy premarket trading. Rite Aid, which sells over-the-counter drugs, personal care...

  • Rite Aid's quarterly profit jumps 46.5 pct Thursday, 18 Dec 2014 | 7:20 AM ET

    Dec 18- U.S. drugstore chain Rite Aid Corp's quarterly profit jumped 46.5 percent as higher sales of prescription drugs boosted same-store sales. The company's net income rose to $104.9 million, or 10 cents per share, in the third quarter ended Nov. 29 from $71.6 million, or 4 cents per share, a year earlier. Total revenue rose 5.3 percent to $6.69 billion.

  • Cramer: Stocks to buy on the next tsunami selloff Wednesday, 17 Dec 2014 | 6:36 PM ET

    It is good to have a game plan the next time the market tanks. These are Jim Cramer's time tested stocks to buy on the next big selloff.

  • Apple just got reinforcements in mobile pay battle Tuesday, 16 Dec 2014 | 11:16 AM ET
    A worker demonstrates Apple Pay inside a mobile kiosk sponsored by Visa and Wells Fargo to demonstrate the new Apple Pay mobile payment system on October 20, 2014 in San Francisco City.

    Dozens more companies—including big banks, retailers and start-ups—have begun to adopt Apple's mobile payments platform, The New York Times reports.

  • What does mobile pay need? A lot more discounts Monday, 8 Dec 2014 | 8:36 AM ET
    A Yankee Candle coupon displayed on an iPhone

    For a technology with huge goals—predicting $27 billion in sales by 2016—mobile payment systems are still stingy with deals and discounts.

  • 'Kickback' flak: Sanofi's caseload grows bigger Friday, 5 Dec 2014 | 4:37 PM ET
    A Sanofi lab worker packages vaccines against the flu.

    Drug giant Sanofi is juggling legal and regulatory issues surrounding three cases involving alleged payments or inducements to medical providers.

  • Lawsuit claims 'kickback' scheme at Sanofi Wednesday, 3 Dec 2014 | 3:27 PM ET
    Ousted Sanofi CEO Christopher Viehbacher

    A lawsuit accuses drug maker Sanofi and top executives, including its ousted CEO, of a million-dollar kickback scheme to promote diabetes drug sales.

  • Sorry Apple Pay, small biz just not that into you Thursday, 6 Nov 2014 | 6:09 PM ET

    It's not just CVS and Rite Aid—small merchants say when it comes to mobile wallets, they're not on the bandwagon either.

  • Can Apple really win the mobile wallet war? Monday, 3 Nov 2014 | 10:10 AM ET
    The new Apple Pay mobile payment system on the iPhone 6

    A fierce battle among virtual wallet providers is heating up. Can Apple Pay for the iPhone 6 gain the strongest foothold over rivals?

  • HSBC to set aside $640M for forex probe Friday, 31 Oct 2014 | 10:46 AM ET

    HSBC is expected to set aside about $640 million to cover the cost of an investigation into suspected manipulation of FX markets. The FT reports.